BioVie Inc. Form PREM14C: Preliminary merger information statement
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2021-05-04: Form PREM14C; Period of report 2021-05-04; Description PRE 14C; Document bivi-14cpre.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2021-05-04 | PREM14C | 2021-05-04 | PRE 14C | bivi-14cpre.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |